Skip to search.
 BSE Down 1.07% NSE Down 1.11%

Isis Pharmaceuticals, Inc. (ISIS)

-NasdaqGS
66.37 Down 1.38(2.03%) 1:30AM
|After Hours : 66.37 0.00 (0.00%) 5:24AM
Add to Portfolio
Prev Close:67.75
Open:67.49
Bid:66.00 x 2000
Ask:66.80 x 1000
1y Target Est:65.80
Beta:1.32
Earnings Date:4 May - 8 May (Est.)
Day's Range:66.20 - 68.15
52wk Range:22.25 - 77.80
Volume:1,751,649
Avg Vol (3m):2,766,120
Market Cap:7.90B
P/E (ttm):N/A
EPS (ttm):-0.33
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for ISIS at this time.

Comparison

Symbol% ChgMkt Cap
ISISDown 2.03%7.90B
ENZDown 0.66%136.58M
GILDDown 1.44%153.79B
SRPTDown 1.76%554.97M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):37.65
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.85
Quarterly EPS Est (Mar-15) :-0.23
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):-3.46

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Isis Pharmaceuticals, Inc. engages in the discovery and development of antisense drugs using novel drug discovery platform. The company’s flagship product includes the KYNAMRO injection, which is an apo-B synthesis inhibitor for patients with... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback